# Changsha Medico Intelligent Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/changsha-medico-intelligent-technology-co

- Industry: Healthcare IT
- Headquarters: Changsha, China
- Website: www.csmadik.com
- Total disclosed funding: $3.5M
- Latest round: Series A (Apr 1, 2022)
- Investors on record: 3

## About

Based in Changsha, China, and established in 2016, Changsha Medico Intelligent Technology Co., Ltd. is a healthcare technology company that engages in R&D, production, and sales of the blood systems and In Vitro Diagnostics (IVD) products. In 2017, it developed a fully automatic sample processing system. The company has a 700 square meters R&D center in Shenzhen, and a 103,000 square meters production plant in Changsha. Its researchers take account 35% of the whole staff. Changsha Medico Intelligent Technology Co., Ltd.'s clients include Sansure, and KHB. The company's products have ISO 13485, ISO 9001, CE, and FDA certifications.

The company's independent research and development products include a sample processing system, automatic sampling system, automatic nucleic acid extractor, remote smart blood bank management platform, intelligent blood storage platform, and liquid handling module. The remote smart blood bank management platform provides services such as vertical blood storage and information management. Its products can be used in the fields of molecular diagnosis, blood screening, enzyme immunoassay, and mass spectrometry.

## Funding rounds

- Series A, Apr 1, 2022, $1.6M — Haier Capital, Sunland Capital
- Seed, May 7, 2021, $0.4M — Yushan Partners
- Seed, Mar 17, 2021, $1.5M — Yushan Partners

## Investors

- Yushan Partners (https://capitalatlas.ai/funds/yushan-partners) — Seed
- Haier Capital (https://capitalatlas.ai/funds/haier-capital) — Series A
- Sunland Capital — Series A